Dolon Revenue and Competitors

Dolon is an international market access consultancy that specialises in rare and severe diseases. We have an exciting international client base of fast-growing companies with innovative and important portfolios of orphan drugs. Working in close partnership with Global and Regional teams, we help them define and communicate the value of their products to payers, policymakers and society. We are constantly updating our knowledge of reimbursement pathways and payer requirements. Our multi-stakeholder network of payers, rare disease experts, industry associations and patient organisations allows us a nuanced understanding of the decision making process and a bird's eye view on the evolving environment of orphan diseases. We use our unique perspective to inform our clients' strategic thinking about rare disease market access, and to help them prepare for pricing and reimbursement negotiations. We provide services in the following areas: • Value Strategy & Communication • Pricing & Reimbursement • Market Access Policy Headquartered in London, Dolon is a small, dynamic, fast-growing company with a strong reputation and a bright future. Our skilled consultants, based throughout Europe, are ready to share their wealth of knowledge to support you in the rare disease market.